{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-066518","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2021-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.637059+00:00","generated_at":"2026-06-27T23:26:51.586079+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pasithea Therapeutics enters new CEO employment agreement with Tiago Reis Marques","bullets":["Base salary $450,000; sign-on bonus $100,000 lump sum after Jan 1, 2022.","Annual discretionary bonus up to 75% of base salary.","Equity grants: 200,000 RSUs and 200,000 options vesting over 3 years (33% after 12 months, then quarterly).","Severance: 12 months base salary if terminated without cause, subject to separation agreement.","Agreement effective January 1, 2022; Board approved equity grants on Dec 20, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-066518","json":"https://secwatch.observer/filing/0001213900-21-066518.json","markdown":"https://secwatch.observer/filing/0001213900-21-066518.md","text":"https://secwatch.observer/filing/0001213900-21-066518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390021066518/0001213900-21-066518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390021066518/ea152745-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:26:51.586079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}